⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14645915 | 0.96 | PDE4B (0.31) | — | |
| SCHEMBL17403188 | 0.94 | — | — | |
| SCHEMBL15808892 | 0.94 | — | — | |
| SCHEMBL3736095 | 0.89 | PDE4B (0.35) | — | |
| SCHEMBL14645916 | 0.88 | — | — | |
| SCHEMBL14645988 | 0.88 | — | — | |
| SCHEMBL15917311 | 0.88 | — | — | |
| SCHEMBL21433858 | 0.87 | — | — | |
| SCHEMBL15808847 | 0.87 | PDE4A (0.31) | — | |
| SCHEMBL29873709 | 0.87 | PTGS2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | claimed |
| US-20160024123-A1 | Asymmetrical Ligands | BOREALIS AG (AT) | 2016-01-28 | — | — | US | claimed |
| EP-2729479-B1 | CATALYSTS | BOREALIS AG (AT) | 2017-09-06 | — | — | EP | disclosed |
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | disclosed |
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | disclosed |
| US-9567351-B2 | Heterophasic copolymers | BOREALIS AG (AT) | 2017-02-14 | — | — | US | disclosed |
| US-9567351-B2 | Heterophasic copolymers | BOREALIS AG (AT) | 2017-02-14 | — | — | US | disclosed |
| EP-2729529-B1 | HETEROPHASIC COPOLYMERS | BOREALIS AG (AT) | 2016-04-27 | — | — | EP | disclosed |
| US-20160024123-A1 | Asymmetrical Ligands | BOREALIS AG (AT) | 2016-01-28 | — | — | US | disclosed |
| US-20160024123-A1 | Asymmetrical Ligands | BOREALIS AG (AT) | 2016-01-28 | — | — | US | disclosed |
| US-20160024123-A1 | Asymmetrical Ligands | BOREALIS AG (AT) | 2016-01-28 | — | — | US | disclosed |
| US-9187583-B2 | Catalysts | BOREALIS AG (AT) | 2015-11-17 | — | — | US | disclosed |
| US-20140221584-A1 | CATALYSTS | BOREALIS AG (AT) | 2014-08-07 | — | — | US | disclosed |
| US-20140221584-A1 | CATALYSTS | BOREALIS AG (AT) | 2014-08-07 | — | — | US | disclosed |
| US-20140221584-A1 | CATALYSTS | BOREALIS AG (AT) | 2014-08-07 | — | — | US | disclosed |
| US-20140206819-A1 | HETEROPHASIC COPOLYMERS | BOREALIS AG (AT) | 2014-07-24 | — | — | US | disclosed |
| US-20140206819-A1 | HETEROPHASIC COPOLYMERS | BOREALIS AG (AT) | 2014-07-24 | — | — | US | disclosed |
| US-20140206819-A1 | HETEROPHASIC COPOLYMERS | BOREALIS AG (AT) | 2014-07-24 | — | — | US | disclosed |
| EP-2729529-A1 | HETEROPHASIC COPOLYMERS | Borealis AG (AT) | 2014-05-14 | — | — | EP | disclosed |
| WO-2013007664-A1 | HETEROPHASIC COPOLYMERS | BOREALIS AG (AT) | 2013-01-17 | — | — | WO | disclosed |